v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:        
Total revenue $ 5,146 $ 4,574 $ 15,377 $ 12,017
Cost of revenue 1,434 1,533 5,162 4,078
Gross profit 3,712 3,041 10,215 7,939
Research and development costs 2,453 2,601 7,270 6,208
Sales and marketing expenses 2,139 1,808 6,171 5,061
General and administrative expenses 2,915 2,436 8,637 6,062
Operating loss (3,795) (3,804) (11,863) (9,392)
Other expense:        
Other (expense) income, net (25) 62 (22) (60)
Interest income (expense), net 32 (238) (165) (809)
Net loss $ (3,788) $ (3,980) $ (12,050) $ (10,261)
Net loss per share attributable to common stockholders:        
Basic (in dollars per share) $ (0.15) $ (0.18) $ (0.50) $ (0.50)
Diluted (in dollars per share) $ (0.15) $ (0.18) $ (0.50) $ (0.50)
Weighted average shares used in computing net loss per share:        
Basic (in shares) 24,497,636 22,522,460 24,058,205 20,545,080
Diluted (in shares) 24,497,636 22,522,460 24,058,205 20,545,080
Product revenue        
Revenue:        
Total revenue $ 3,130 $ 3,338 $ 9,750 $ 8,863
Service and other revenue        
Revenue:        
Total revenue $ 2,016 $ 1,236 $ 5,627 $ 3,154

Source